Speaker:
Ted W. Love, M.D.
President and Chief Executive Officer (CEO), Global Blood Therapeutics
Summary of Session Goals:
The goal of this session is to provide background on PCORI and discuss comparative effectiveness research, engagement, and dissemination and implementation funding opportunities.
Learning Objectives:
1. Understand the origin and molecular basis of Sickle Cell Disease
2. Understand a potential drug discovery strategy to modify Sickle Cell Disease
3. Gain an overview of the drug development and approval process
A Live Webcast Sponsored By:
The Rockefeller University Hospital Center for Clinical and Translational Science and Clinical Directors Network, Inc. (CDN)
Date:
Wednesday, October 17, 2018 from 12:00 PM to 1:00 PM EDT
Evaluation –
This webcast has been approved for up to 1.0 prescribed Continuing Medical Education (CME) and Continuing Nursing Education (CNE) credits by the American Academy of Family Physicians (AAFP). Please Click Here! to complete the evaluations for enduring CME Credits.
Slideset-
Targeted Drug Discovery in Sickle Cell Disease: From Concept to Clinic (PDF)
Evaluations-
This webcast is approved for up to 1.0 Prescribed CME credits by the American Academy of Family Physicians (AAFP).
